The price of ICUI is predicted to go up -8.66%, based on the high correlation periods with SONY. The similarity of these two price pattern on the periods is 92.32%.
ICUI
SONY
Management has done an impressive job deepening ICU's consumables portfolio through acquisitions and bolstering its leading position in this attractive end market.
ICU will have the opportunity to cross-sell to existing Smiths Medical accounts and vice versa, which looks promising, given their differing geographic footprints.
ICU has an attractive runway to improve margins, given the current inefficiencies in the Smiths integration.
Jefferies
2024-12-11
Price Target
$200
Upside
+20.34%
Keybanc
2024-11-13
Price Target
$198 → $209
Upside
+19.56%
Keybanc
2024-10-15
Price Target
$147 → $198
Upside
+10.31%